---
title: "XJZY obtained the domestic production drug registration certificate for estradiol tablets"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258057685.md"
description: "According to the Zhitong Finance APP, XJZY announced that the company recently received the \"Drug Registration Certificate\" for estradiol tablets approved and issued by the National Medical Products Administration. The company's estradiol tablets have been approved for registration. The indications for estradiol tablets are for diseases related to estrogen deficiency and can also be used to prevent osteoporosis"
datetime: "2025-09-19T09:49:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258057685.md)
  - [en](https://longbridge.com/en/news/258057685.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258057685.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/258057685.md) | [繁體中文](https://longbridge.com/zh-HK/news/258057685.md)


# XJZY obtained the domestic production drug registration certificate for estradiol tablets

According to the Zhitong Finance APP, XJZY (002332.SZ) announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration for estradiol tablets, which have been approved for registration. The indications for estradiol tablets are for diseases related to estrogen deficiency and can also be used to prevent osteoporosis

### Related Stocks

- [XJZY (002332.CN)](https://longbridge.com/en/quote/002332.CN.md)

## Related News & Research

- [Nine out of 10 bets this fund manager made outperformed over the past year. Here's his next two plays.](https://longbridge.com/en/news/277192065.md)
- [Changchun High-Tech Industry Files Clinical Trial Application for GenSci161 Injection](https://longbridge.com/en/news/277574518.md)
- [January CPI Revives Rate-Cut Hopes; Gold and Silver Rebound, But Is the Bull Run Intact?](https://longbridge.com/en/news/277142018.md)
- [Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China](https://longbridge.com/en/news/277568022.md)
- [SSY Group's Respiratory Drug Approved for Production in China](https://longbridge.com/en/news/277561555.md)